Analyst Reco. BioArctic AB

Equities

BIOA B

SE0010323311

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 13/03/2026 pm IST			5-day change	1st Jan Change
302.40 ^SEK	-1.43%		+1.20%	-2.70%

12/03	Scandibio recruits 200 patients for Phase 3 Alzheimer's study	FW
11/03	BioArctic partner to present long-term lecanemab data at AD/PD conference	FW

Analyst Reco.

20/02	Nordea Raises Price Target for Bioarctic to 240 Kronor (236), Reiterates Sell	FW
19/02	Goldman Sachs Raises Price Target for Bioarctic to 367 Kronor (346), Reiterates Buy - BN	FW
16/02	Bioarctic Expected to Report -35.9 Million in Operating Result - Modular Finance	FW
09/02	DNB Carnegie Raises Price Target for Bioarctic to 342 Kronor (334), Reiterates Buy	FW
05/02	Goldman Sachs Raises Price Target for Bioarctic to SEK 346 (339), Reiterates Buy - BN	FW
04/02	Nordea Raises Target Price for Bioarctic to 236 Kronor (230), Reiterates Sell	FW
05/01	Bioarctic Likely to Begin Dividend Payments in 2027 - Di	FW
25/11	Goldman Sachs Lowers Price Target for Bioarctic to SEK 339 (from SEK 355), Reiterates Buy Rating - BN	FW
19/11	SHB Reiterates Buy on Bioarctic - Lowers This Year's Profit Forecast but Raises Outlook for Coming Years	FW
18/11	DNB Carnegie Raises Target Price for Bioarctic to 334 Kronor, Reiterates Buy	FW
14/11	Nordea Raises Target Price for Bioarctic to SEK 230 (220), Reiterates Sell	FW
24/25/24	Goldman Sachs Raises Price Target for Bioarctic to SEK 355, Reiterates Buy - BN	FW
21/25/21	DNB Carnegie Lowers Target Price for Bioarctic to SEK 329 (330), Reiterates Buy	FW
09/25/09	Nordea Reiterates Sell Rating on Bioarctic, Citing Overvaluation and Slow Leqembi Uptake	FW
08/25/08	Bioarctic Rises Following Buy Recommendation from Handelsbanken	FW
08/25/08	Stockholm Bullets - ABB and Xspray Pharma in the spotlight	FW
08/25/08	Handelsbanken Initiates Coverage of Bioarctic with Buy Recommendation and Target Price of SEK 355	FW
01/25/01	Bristol-Myers Squibb Receives FDA Fast Track for Alzheimer's Drug	FW
29/25/29	Stockholm Bullets: Gaming Companies Among Monday's Winners	FW
25/25/25	Jefferies sees positive triggers for Biogen's stock - initiates with a buy rating.	FW
23/25/23	Bernstein Observes Signs of Sales Momentum for Leqembi	FW
16/25/16	Affärsvärlden Issues Neutral Recommendation for Bioarctic	FW
16/25/16	Affärsvärlden Recommends Hold for Bioarctic	FW
05/25/05	Nordea Downgrades Bioarctic to Sell (Hold), Sets Target Price at SEK 220	FW
02/25/02	Goldman Sachs Raises Price Target for Bioarctic to SEK 353 (232), Reiterates Buy - BN	FW